Vazquez Chris's Form 4 filing
Biodesix Inc (BDSX) · filed Nov 13, 2024
- Accession no.
- 0000905148-24-003059
- Filed
- Nov 13, 2024
- Trade date
- Nov 8-12, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $283.15. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vazquez ChrisCIK 0001980594 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | Common Stock | MOption exerciseAcquired | +602 | – | – | 11,790 | Direct | |
| Nov 11, 2024 | Common Stock | SSaleDisposed | −105 | $1.39 | −$145.95 | 11,685 | Direct | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −98 | $1.40 | −$137.2 | 11,587 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | Common Stock | MOption exerciseDisposed | −602 | $0.00 | $0 | 3,008 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.